Tesamorelin 10mg Research Peptide
Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH). The trans-3-hexenoic acid modification at the N-terminus protects it from rapid enzymatic degradation, giving it a longer plasma half-life than native GHRH.
Purity
99.4% HPLC-tested purity with COA support.
Size
10mg Lyophilized Powder.
Storage
-20°C (Freezer)
Research use
For laboratory research use only. Not for human or veterinary use.
Mechanism of action
Tesamorelin binds GHRH receptors on the anterior pituitary, stimulating pulsatile release of endogenous growth hormone. Unlike exogenous HGH, it preserves the body's natural feedback loop. Clinical trials in HIV-associated lipodystrophy show selective reduction of visceral adipose tissue without affecting subcutaneous fat.
Research applications
- Visceral adipose tissue research
- HIV-associated lipodystrophy studies
- IGF-1 axis and metabolic research
- Cognitive aging and MCI studies
- Lean mass preservation research
Frequently asked questions
How is Tesamorelin different from CJC-1295?
Tesamorelin is a full 44-amino-acid GHRH analog with a hexenoyl modification. CJC-1295 is a shorter GRF(1-29) fragment. Tesamorelin has stronger published data for visceral fat reduction specifically.
What does Tesamorelin research show on visceral fat?
Phase III trials in HIV-lipodystrophy showed ~15-18% reduction in visceral adipose tissue over 26 weeks, with no effect on subcutaneous fat or insulin sensitivity.
Do you provide a Certificate of Analysis?
Yes. Every vial of Tesamorelin ships with a third-party COA showing ≥99.4% HPLC purity, mass spec confirmation and endotoxin testing.
Browse research peptides for sale · View lab reports · Read peptide FAQ